[Chilean experience with the use of 18F-deoxyglucose positron emission tomography]. / Análisis de 1.000 casos de estudios metabólocos en Chile con PET 18Flúor-deoxiglucosa (FDG).
Rev Med Chil
; 135(3): 375-83, 2007 Mar.
Article
em Es
| MEDLINE
| ID: mdl-17505585
BACKGROUND: Clinical oncology is the main application of 18F-deoxyglucose (FDG) positron emission tomography (PET). AIM: To evaluate the first 1,000 patients studied with FDG PET in Chile. MATERIAL AND METHODS: Retrospective analysis of 1,000 patients (aged between 1 and 94 years, 550 females) studied with FDG PET, since 2003. All studies were performed in a high resolution Siemens Ecat-Exact HR (+). All reports were based on the visual analysis of three plane and three-dimensional images. RESULTS: Ninety seven percent of exams were done for oncological indications, mainly lung lesions, lymphoma, colorectal and gastroesophageal, cancer and breast tumors. Only 1% of patients had brain tumors. Non tumor neurological indications corresponded to 1.7%. Cardiac studies were only 0.3% and inflammatory process corresponded to 1%. The 5.6% corresponded to pediatric population. Six percent of patients were aged less than 18 years and in 50% of them, the indication was oncological, mainly lymphomas, brain tumors, endocrine cancers and sarcomas. The remaining 50% had a neurological indications, mainly for refractory epilepsy. CONCLUSIONS: PET FDG imaging was effective in the management of diverse diseases of children and adults.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Compostos Radiofarmacêuticos
/
Fluordesoxiglucose F18
/
Tomografia por Emissão de Pósitrons
/
Neoplasias
Tipo de estudo:
Observational_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
País/Região como assunto:
America do sul
/
Chile
Idioma:
Es
Revista:
Rev Med Chil
Ano de publicação:
2007
Tipo de documento:
Article
País de afiliação:
Chile
País de publicação:
Chile